The Graduate Research Training Program PharMetrX: Pharmacometrics & Computational Disease Modelling is a joint initiative in Germany between the Freie Universität Berlin and the Universität Potsdam, bridging pharmacy and mathematics, supported by the research-driven pharmaceutical companies AbbVie Deutschland GmbH & Co. KG, Boehringer Ingelheim Pharma GmbH & Co. KG, F. Hoffmann-La Roche Ltd, Grünenthal GmbH, Merck KGaA and SANOFI.
It offers its graduate students a unique opportunity to experience research in the area of drug development and optimising drug therapy jointly within academia and industry.
The interdisciplinary PhD program is designed as a 3.5 year research program including a structured research training curriculum of advanced academic & industrial modules and a competitive research fellowship. Yearly call for application from July to mid September, to start March the following year.
NOTE FOR APPLICANTS: Unfortunately, we faced a problem with resolving internet addresses at the institute from Tuesday, Sept. 12th (lunch time) to 13th (morning), that has meanwhile be resolved. Emails that could not be delivered are typically resend, and access to the online platform is now provided again. Sorry for this inconvenience. - PharMetrX